-
1
-
-
84925855500
-
Current contraceptive status among women aged 15–44: United States, 2011–2013
-
[1] Daniels, K., Daugherty, J., Jones, J., Current contraceptive status among women aged 15–44: United States, 2011–2013. NCHS Data Brief. 173 (2014), 1–8.
-
(2014)
NCHS Data Brief.
, vol.173
, pp. 1-8
-
-
Daniels, K.1
Daugherty, J.2
Jones, J.3
-
2
-
-
84906042811
-
-
U Nations
-
[2] DoEaS Affairs, Nations, U, (eds.) World Contraceptive Pattern, 2013 http://www.un.org/en/development/desa/population/publications/family/contraceptive-wallchart-2013.shtml2013.
-
(2013)
World Contraceptive Pattern
-
-
DoEaS Affairs1
-
3
-
-
84939215662
-
Use of combined oral contraceptives and risk of venous thromboembolism: nested case-control studies using the QResearch and CPRD databases
-
[3] Vinogradova, Y., Coupland, C., Hippisley-Cox, J., Use of combined oral contraceptives and risk of venous thromboembolism: nested case-control studies using the QResearch and CPRD databases. BMJ, 350, 2015, h2135.
-
(2015)
BMJ
, vol.350
, pp. h2135
-
-
Vinogradova, Y.1
Coupland, C.2
Hippisley-Cox, J.3
-
4
-
-
84942825497
-
Combined oral contraceptives and risk of venous thromboembolism: there is higher risk in new generations compared to second generations, but paradoxically not in norgestimate-containing-pills
-
[4] Plu-Bureau, G., Combined oral contraceptives and risk of venous thromboembolism: there is higher risk in new generations compared to second generations, but paradoxically not in norgestimate-containing-pills. Evidence Based Medicine, 20, 2015, 189.
-
(2015)
Evidence Based Medicine
, vol.20
, pp. 189
-
-
Plu-Bureau, G.1
-
5
-
-
84983406373
-
Risk factors for venous thromboembolism in women under combined oral contraceptive
-
[5] Suchon, P., Al Frouh, F., Henneuse, A., Ibrahim, M., Brunet, D., Barthet, M.-C., et al. Risk factors for venous thromboembolism in women under combined oral contraceptive. Thromb. Haemost., 2015.
-
(2015)
Thromb. Haemost.
-
-
Suchon, P.1
Al Frouh, F.2
Henneuse, A.3
Ibrahim, M.4
Brunet, D.5
Barthet, M.-C.6
-
6
-
-
84962283918
-
Fresh evidence confirms links between newer contraceptive pills and higher risk of venous thromboembolism
-
[6] Jick, S.S., Fresh evidence confirms links between newer contraceptive pills and higher risk of venous thromboembolism. BMJ, 350, 2015, h2422.
-
(2015)
BMJ
, vol.350
, pp. h2422
-
-
Jick, S.S.1
-
7
-
-
84872156834
-
The induction of microRNA-16 in colon cancer cells by protein arginine deiminase inhibition causes a p53-dependent cell cycle arrest
-
e53791
-
[7] Cui, X., Witalison, E.E., Chumanevich, A.P., Chumanevich, A.A., Poudyal, D., Subramanian, V., et al. The induction of microRNA-16 in colon cancer cells by protein arginine deiminase inhibition causes a p53-dependent cell cycle arrest. PLoS One, 8, 2013, e53791.
-
(2013)
PLoS One
, vol.8
-
-
Cui, X.1
Witalison, E.E.2
Chumanevich, A.P.3
Chumanevich, A.A.4
Poudyal, D.5
Subramanian, V.6
-
8
-
-
14844333590
-
Contrasting effects of estradiol and 17B — aminoestrogens on blood clotting time in rats and mice
-
[8] Lemini, C.F.Y., M.E, A., R., J., Contrasting effects of estradiol and 17B — aminoestrogens on blood clotting time in rats and mice. Eur. J. Pharmacol. 510 (2005), 229–233.
-
(2005)
Eur. J. Pharmacol.
, vol.510
, pp. 229-233
-
-
Lemini, C.F.Y.1
M.E, A.2
R., J.3
-
9
-
-
0033690895
-
The mechanisms of estrogen regulation of bone resorption
-
[9] Riggs, B.L., The mechanisms of estrogen regulation of bone resorption. JCI. 10 (2000), 1203–1204.
-
(2000)
JCI.
, vol.10
, pp. 1203-1204
-
-
Riggs, B.L.1
-
10
-
-
84904470952
-
Estrogen causes ultrastructural changes of fibrin networks during the menstrual cycle: a qualitative investigation
-
[10] LBG, S.A.C., P.J, S., Abdool, Z., E., P., Estrogen causes ultrastructural changes of fibrin networks during the menstrual cycle: a qualitative investigation. Microsc. Res. Tech. 77 (2014), 594–601.
-
(2014)
Microsc. Res. Tech.
, vol.77
, pp. 594-601
-
-
LBG, S.A.C.1
P.J, S.2
Abdool, Z.3
E., P.4
-
11
-
-
0037968650
-
Genetic variants of coagulation factor XIII, postmenopausal estrogen therapy, and risk of nonfatal myocardial infarction
-
[11] HR, R.A.P., H.L, V., R.A.S, A., R.N, L., N.L, S., et al. Genetic variants of coagulation factor XIII, postmenopausal estrogen therapy, and risk of nonfatal myocardial infarction. Blood Journal 120 (2003), 25–30.
-
(2003)
Blood Journal
, vol.120
, pp. 25-30
-
-
HR, R.A.P.1
H.L, V.2
R.A.S, A.3
R.N, L.4
N.L, S.5
-
12
-
-
0035799341
-
Inflammation and thrombosis the clot thickens
-
[12] Libby, P., Simon, D.I., Inflammation and thrombosis the clot thickens. Circulation 103 (2001), 1718–1720.
-
(2001)
Circulation
, vol.103
, pp. 1718-1720
-
-
Libby, P.1
Simon, D.I.2
-
13
-
-
84894073629
-
Reactive oxygen species in inflammation and tissue injury
-
[13] Mittal, M., Siddiqui, M.R., Tran, K., Reddy, S.P., Malik, A.B., Reactive oxygen species in inflammation and tissue injury. Antioxid. Redox Signal. 20 (2014), 1126–1167.
-
(2014)
Antioxid. Redox Signal.
, vol.20
, pp. 1126-1167
-
-
Mittal, M.1
Siddiqui, M.R.2
Tran, K.3
Reddy, S.P.4
Malik, A.B.5
-
14
-
-
77949305755
-
Inflammation, innate immunity and blood coagulation
-
[14] Xu, J., Lupu, F., Esmon, C., Inflammation, innate immunity and blood coagulation. Hamostaseologie, 30, 2010, 5.
-
(2010)
Hamostaseologie
, vol.30
, pp. 5
-
-
Xu, J.1
Lupu, F.2
Esmon, C.3
-
15
-
-
84866253982
-
Thrombomodulin: a bifunctional modulator of inflammation and coagulation in sepsis
-
[15] Okamoto, T., Tanigami, H., Suzuki, K., Shimaoka, M., Thrombomodulin: a bifunctional modulator of inflammation and coagulation in sepsis. Critical Care Research and Practice, 2012, 2012.
-
(2012)
Critical Care Research and Practice
, vol.2012
-
-
Okamoto, T.1
Tanigami, H.2
Suzuki, K.3
Shimaoka, M.4
-
16
-
-
11144235191
-
Nongenomic effects of 17B-estradiol in human platelets: potentiation of thrombin-induced aggregation through estrogen receptor B and Src kinase
-
[16] Moro, L.R.S., Piranda, D., Pietrapiana, D., Lova, P., Bertoni, A., et al. Nongenomic effects of 17B-estradiol in human platelets: potentiation of thrombin-induced aggregation through estrogen receptor B and Src kinase. Blood 105 (2005), 115–121.
-
(2005)
Blood
, vol.105
, pp. 115-121
-
-
Moro, L.R.S.1
Piranda, D.2
Pietrapiana, D.3
Lova, P.4
Bertoni, A.5
-
17
-
-
84948717312
-
Thromboelastography identifies cyclic haemostatic variations in healthy women using oral contraceptives
-
[17] Murray EKI, Murphy MSQ, Smith GN, Hopman WM, Othman M, Graham CH. Thromboelastography identifies cyclic haemostatic variations in healthy women using oral contraceptives. Thromb. Res. 136:1022–1026.
-
Thromb. Res.
, vol.136
, pp. 1022-1026
-
-
Murray, E.K.I.1
Murphy, M.S.Q.2
Smith, G.N.3
Hopman, W.M.4
Othman, M.5
Graham, C.H.6
-
18
-
-
85028789103
-
C0230 Oral contraceptives and thrombophilia
-
[18] Stasko J, Bartosova L, Chudy P, Chuda D, Sokol J, Jedinakova Z, et al. C0230 Oral contraceptives and thrombophilia. Thromb. Res.130:S176.
-
Thromb. Res.
, vol.130
, pp. S176
-
-
Stasko, J.1
Bartosova, L.2
Chudy, P.3
Chuda, D.4
Sokol, J.5
Jedinakova, Z.6
-
19
-
-
84949221494
-
Thromboembolism as the adverse event of combined oral contraceptives in Japan
-
[19] Sugiura K, Kobayashi T, Ojima T. Thromboembolism as the adverse event of combined oral contraceptives in Japan. Thromb. Res.136:1110–1115.
-
Thromb. Res.
, vol.136
, pp. 1110-1115
-
-
Sugiura, K.1
Kobayashi, T.2
Ojima, T.3
-
20
-
-
84931575226
-
Current use of oral contraceptives and the risk of first-ever ischemic stroke: a meta-analysis of observational studies
-
[20] Xu Z, Li Y, Tang S, Huang X, Chen T. Current use of oral contraceptives and the risk of first-ever ischemic stroke: a meta-analysis of observational studies. Thromb. Res.136:52–60.
-
Thromb. Res.
, vol.136
, pp. 52-60
-
-
Xu, Z.1
Li, Y.2
Tang, S.3
Huang, X.4
Chen, T.5
-
21
-
-
73349119137
-
Pregnancy and laboratory studies: a reference table for clinicians
-
[21] Abbassi-Ghanavati, M., Greer, L.G., Cunningham, F.G., Pregnancy and laboratory studies: a reference table for clinicians. Obstet. Gynecol. 114 (2009), 1326–1331.
-
(2009)
Obstet. Gynecol.
, vol.114
, pp. 1326-1331
-
-
Abbassi-Ghanavati, M.1
Greer, L.G.2
Cunningham, F.G.3
-
22
-
-
4744361075
-
Laboratory reference values
-
[22] Kratz, A., Ferraro, M., Sluss, P.M., Lewandrowski, K.B., Laboratory reference values. N. Engl. J. Med. 351 (2004), 1548–1564.
-
(2004)
N. Engl. J. Med.
, vol.351
, pp. 1548-1564
-
-
Kratz, A.1
Ferraro, M.2
Sluss, P.M.3
Lewandrowski, K.B.4
-
23
-
-
12844278573
-
Reduced plasma fibrinolytic potential is a risk factor for venous thrombosis
-
[23] Lisman, T., de Groot, P.G., Meijers, J.C., Rosendaal, F.R., Reduced plasma fibrinolytic potential is a risk factor for venous thrombosis. Blood 105 (2005), 1102–1105.
-
(2005)
Blood
, vol.105
, pp. 1102-1105
-
-
Lisman, T.1
de Groot, P.G.2
Meijers, J.C.3
Rosendaal, F.R.4
-
24
-
-
84867263665
-
Biological variation in tPA-induced plasma clot lysis time
-
[24] Talens, S., Malfliet, J.J., Rudez, G., Spronk, H.M., Janssen, N.A., Meijer, P., et al. Biological variation in tPA-induced plasma clot lysis time. Thromb. Haemost. 108 (2012), 640–646.
-
(2012)
Thromb. Haemost.
, vol.108
, pp. 640-646
-
-
Talens, S.1
Malfliet, J.J.2
Rudez, G.3
Spronk, H.M.4
Janssen, N.A.5
Meijer, P.6
-
25
-
-
84869051730
-
Plasma clot lysis time and its association with cardiovascular risk factors in black Africans
-
e48881
-
[25] de Lange, Z., Pieters, M., Jerling, J.C., Kruger, A., Rijken, D.C., Plasma clot lysis time and its association with cardiovascular risk factors in black Africans. PLoS One, 7, 2012, e48881.
-
(2012)
PLoS One
, vol.7
-
-
de Lange, Z.1
Pieters, M.2
Jerling, J.C.3
Kruger, A.4
Rijken, D.C.5
-
26
-
-
84919429343
-
Measurement of the Nanoscale Roughness by Atomic Force Microscopy: Basic Principles and Applications
-
INTECH Open Access Publisher
-
[26] De Oliveira, R., Albuquerque, D., Leite, F., Yamaji, F., Cruz, T., Measurement of the Nanoscale Roughness by Atomic Force Microscopy: Basic Principles and Applications. 2012, INTECH Open Access Publisher.
-
(2012)
-
-
De Oliveira, R.1
Albuquerque, D.2
Leite, F.3
Yamaji, F.4
Cruz, T.5
-
27
-
-
84927606141
-
CVD risk factors are related to plasma fibrin clot properties independent of total and or gamma' fibrinogen concentration
-
[27] Kotze, R.C., Ariens, R.A., de Lange, Z., Pieters, M., CVD risk factors are related to plasma fibrin clot properties independent of total and or gamma' fibrinogen concentration. Thromb. Res. 134 (2014), 963–969.
-
(2014)
Thromb. Res.
, vol.134
, pp. 963-969
-
-
Kotze, R.C.1
Ariens, R.A.2
de Lange, Z.3
Pieters, M.4
-
28
-
-
84957990642
-
Multi-scale strain-stiffening of semiflexible bundle networks
-
[28] Piechocka, I.K., Jansen, K.A., Broedersz, C.P., NA, K., FC, M.K., GH, K., Multi-scale strain-stiffening of semiflexible bundle networks. Soft Matter, 2016.
-
(2016)
Soft Matter
-
-
Piechocka, I.K.1
Jansen, K.A.2
Broedersz, C.P.3
NA, K.4
FC, M.K.5
GH, K.6
-
29
-
-
84899748941
-
Roles of fibrin alpha- and gamma-chain specific cross-linking by FXIIIa in fibrin structure and function
-
[29] Duval, C., Allan, P., Connell, S.D., Ridger, V.C., Philippou, H., Ariens, R.A., Roles of fibrin alpha- and gamma-chain specific cross-linking by FXIIIa in fibrin structure and function. Thromb. Haemost. 111 (2014), 842–850.
-
(2014)
Thromb. Haemost.
, vol.111
, pp. 842-850
-
-
Duval, C.1
Allan, P.2
Connell, S.D.3
Ridger, V.C.4
Philippou, H.5
Ariens, R.A.6
-
30
-
-
84923862266
-
Physical determinants of fibrinolysis in single fibrin fibers
-
e0116350
-
[30] Bucay, I., O'Brien, E.T. III, Wulfe, S.D., Superfine, R., Wolberg, A.S., Falvo, M.R., et al. Physical determinants of fibrinolysis in single fibrin fibers. PLoS One, 10, 2015, e0116350.
-
(2015)
PLoS One
, vol.10
-
-
Bucay, I.1
O'Brien, E.T.2
Wulfe, S.D.3
Superfine, R.4
Wolberg, A.S.5
Falvo, M.R.6
-
31
-
-
0034022885
-
Influence of fibrin network conformation and fibrin fiber diameter on fibrinolysis speed dynamic and structural approaches by confocal microscopy
-
[31] Collet, J., Park, D., Lesty, C., Soria, J., Soria, C., Montalescot, G., et al. Influence of fibrin network conformation and fibrin fiber diameter on fibrinolysis speed dynamic and structural approaches by confocal microscopy. Arterioscler. Thromb. Vasc. Biol. 20 (2000), 1354–1361.
-
(2000)
Arterioscler. Thromb. Vasc. Biol.
, vol.20
, pp. 1354-1361
-
-
Collet, J.1
Park, D.2
Lesty, C.3
Soria, J.4
Soria, C.5
Montalescot, G.6
-
32
-
-
0026771894
-
Computer modeling of fibrin polymerization kinetics correlated with electron microscope and turbidity observations: clot structure and assembly are kinetically controlled
-
[32] Weisel, J.W., Nagaswami, C., Computer modeling of fibrin polymerization kinetics correlated with electron microscope and turbidity observations: clot structure and assembly are kinetically controlled. Biophys. J., 63, 1992, 111.
-
(1992)
Biophys. J.
, vol.63
, pp. 111
-
-
Weisel, J.W.1
Nagaswami, C.2
-
33
-
-
4444376338
-
Genetic and environmental determinants of fibrin structure and function: relevance to clinical disease
-
[33] Scott, E.M., Ariëns, R.A.S., Grant, P.J., Genetic and environmental determinants of fibrin structure and function: relevance to clinical disease. Arterioscler. Thromb. Vasc. Biol. 24 (2004), 1558–1566.
-
(2004)
Arterioscler. Thromb. Vasc. Biol.
, vol.24
, pp. 1558-1566
-
-
Scott, E.M.1
Ariëns, R.A.S.2
Grant, P.J.3
-
34
-
-
0037534900
-
Elevated prothrombin results in clots with an altered fiber structure: a possible mechanism of the increased thrombotic risk
-
[34] Wolberg, A.S., Monroe, D.M., Roberts, H.R., Hoffman, M., Elevated prothrombin results in clots with an altered fiber structure: a possible mechanism of the increased thrombotic risk. Blood 101 (2003), 3008–3013.
-
(2003)
Blood
, vol.101
, pp. 3008-3013
-
-
Wolberg, A.S.1
Monroe, D.M.2
Roberts, H.R.3
Hoffman, M.4
-
35
-
-
0028143826
-
Differential susceptibility of plasma proteins to oxidative modification: examination by Western blot immunoassay
-
[35] Shacter, E., Williams, J.A., Lim, M., Levine, R.L., Differential susceptibility of plasma proteins to oxidative modification: examination by Western blot immunoassay. Free Radic. Biol. Med. 17 (1994), 429–437.
-
(1994)
Free Radic. Biol. Med.
, vol.17
, pp. 429-437
-
-
Shacter, E.1
Williams, J.A.2
Lim, M.3
Levine, R.L.4
-
36
-
-
84887469426
-
The effect of reagents mimicking oxidative stress on fibrinogen function
-
[36] Štikarová, J., Kotlín, R., Riedel, T., Suttnar, J., Pimková, K., Chrastinová, L., et al. The effect of reagents mimicking oxidative stress on fibrinogen function. Sci. World J., 2013, 2013.
-
(2013)
Sci. World J.
, vol.2013
-
-
Štikarová, J.1
Kotlín, R.2
Riedel, T.3
Suttnar, J.4
Pimková, K.5
Chrastinová, L.6
-
37
-
-
84878018470
-
Estrogen and estrogen receptors in cardiovascular oxidative stress
-
[37] Arias-Loza, P.-A., Muehlfelder, M., Pelzer, T., Estrogen and estrogen receptors in cardiovascular oxidative stress. Pflügers Archiv-European Journal of Physiology 465 (2013), 739–746.
-
(2013)
Pflügers Archiv-European Journal of Physiology
, vol.465
, pp. 739-746
-
-
Arias-Loza, P.-A.1
Muehlfelder, M.2
Pelzer, T.3
-
38
-
-
79954482502
-
Chronic estradiol exposure induces oxidative stress in the hypothalamus to decrease hypothalamic dopamine and cause hyperprolactinemia
-
[38] MohanKumar, S.M., Kasturi, B.S., Shin, A.C., Balasubramanian, P., Gilbreath, E.T., Subramanian, M., et al. Chronic estradiol exposure induces oxidative stress in the hypothalamus to decrease hypothalamic dopamine and cause hyperprolactinemia. Am. J. Phys. Regul. Integr. Comp. Phys. 300 (2011), R693–R699.
-
(2011)
Am. J. Phys. Regul. Integr. Comp. Phys.
, vol.300
, pp. R693-R699
-
-
MohanKumar, S.M.1
Kasturi, B.S.2
Shin, A.C.3
Balasubramanian, P.4
Gilbreath, E.T.5
Subramanian, M.6
-
39
-
-
84956940867
-
Exposure to 17beta-oestradiol induces oxidative stress in the non-oestrogen receptor invertebrate species Eisenia fetida
-
e0145426
-
[39] Heger, Z., Michalek, P., Guran, R., Havelkova, B., Kominkova, M., Cernei, N., et al. Exposure to 17beta-oestradiol induces oxidative stress in the non-oestrogen receptor invertebrate species Eisenia fetida. PLoS One, 10, 2015, e0145426.
-
(2015)
PLoS One
, vol.10
-
-
Heger, Z.1
Michalek, P.2
Guran, R.3
Havelkova, B.4
Kominkova, M.5
Cernei, N.6
-
40
-
-
0031755366
-
Estradiol as an antioxidant: incompatible with its physiological concentrations and function
-
[40] Santanam, N., Shern-Brewer, R., McClatchey, R., Castellano, P.Z., Murphy, A.A., Voelkel, S., et al. Estradiol as an antioxidant: incompatible with its physiological concentrations and function. J. Lipid Res. 39 (1998), 2111–2118.
-
(1998)
J. Lipid Res.
, vol.39
, pp. 2111-2118
-
-
Santanam, N.1
Shern-Brewer, R.2
McClatchey, R.3
Castellano, P.Z.4
Murphy, A.A.5
Voelkel, S.6
-
41
-
-
77950635369
-
Thrombin flux and wall shear rate regulate fibrin fiber deposition state during polymerization under flow
-
[41] Neeves, K., Illing, D., Diamond, S., Thrombin flux and wall shear rate regulate fibrin fiber deposition state during polymerization under flow. Biophys. J. 98 (2010), 1344–1352.
-
(2010)
Biophys. J.
, vol.98
, pp. 1344-1352
-
-
Neeves, K.1
Illing, D.2
Diamond, S.3
-
42
-
-
84924207633
-
Structure of fibrin gels studied by elastic light scattering techniques: dependence of fractal dimension, gel crossover length, fiber diameter, and fiber density on monomer concentration
-
[42] Ferri, F., Greco, M., Arcovito, G., De Spirito, M., Rocco, M., Structure of fibrin gels studied by elastic light scattering techniques: dependence of fractal dimension, gel crossover length, fiber diameter, and fiber density on monomer concentration. Phys. Rev. E, 66, 2002, 011913.
-
(2002)
Phys. Rev. E
, vol.66
, pp. 011913
-
-
Ferri, F.1
Greco, M.2
Arcovito, G.3
De Spirito, M.4
Rocco, M.5
-
43
-
-
77958474678
-
Nanostructure of the fibrin clot
-
[43] Yeromonahos, C., Polack, B., Caton, F., Nanostructure of the fibrin clot. Biophys. J. 99 (2010), 2018–2027.
-
(2010)
Biophys. J.
, vol.99
, pp. 2018-2027
-
-
Yeromonahos, C.1
Polack, B.2
Caton, F.3
-
44
-
-
0035940439
-
Crystal structure of native chicken fibrinogen at 2.7 Å resolution
-
[44] Yang, Z., Kollman, J.M., Pandi, L., Doolittle, R.F., Crystal structure of native chicken fibrinogen at 2.7 Å resolution. Biochemistry 40 (2001), 12515–12523.
-
(2001)
Biochemistry
, vol.40
, pp. 12515-12523
-
-
Yang, Z.1
Kollman, J.M.2
Pandi, L.3
Doolittle, R.F.4
-
45
-
-
0032130915
-
Molecular arrangement of adsorbed fibrinogen molecules characterized by specific monoclonal antibodies and a surface plasmon resonance sensor
-
[45] Dyr, J.E., Tichý, I., Jiroušková, M., Tobiška, P., Slavık, R., Homola, J., et al. Molecular arrangement of adsorbed fibrinogen molecules characterized by specific monoclonal antibodies and a surface plasmon resonance sensor. Sensors Actuators B Chem. 51 (1998), 268–272.
-
(1998)
Sensors Actuators B Chem.
, vol.51
, pp. 268-272
-
-
Dyr, J.E.1
Tichý, I.2
Jiroušková, M.3
Tobiška, P.4
Slavık, R.5
Homola, J.6
-
46
-
-
79551624917
-
Fibrinopeptides A and B release in the process of surface fibrin formation
-
[46] Riedel, T., Suttnar, J., Brynda, E., Houska, M., Medved, L., Dyr, J.E., Fibrinopeptides A and B release in the process of surface fibrin formation. Blood 117 (2011), 1700–1706.
-
(2011)
Blood
, vol.117
, pp. 1700-1706
-
-
Riedel, T.1
Suttnar, J.2
Brynda, E.3
Houska, M.4
Medved, L.5
Dyr, J.E.6
-
47
-
-
84875288786
-
Human fibrinogen monolayers on latex particles: role of ionic strength
-
[47] Bratek-Skicki, A., Żeliszewska, P., Adamczyk, Z., Cieśla, M., Human fibrinogen monolayers on latex particles: role of ionic strength. Langmuir 29 (2013), 3700–3710.
-
(2013)
Langmuir
, vol.29
, pp. 3700-3710
-
-
Bratek-Skicki, A.1
Żeliszewska, P.2
Adamczyk, Z.3
Cieśla, M.4
-
48
-
-
0026173801
-
Effect of surface hydrophobicity on the conformational changes of adsorbed fibrinogen
-
[48] Lu, D.R., Park, K., Effect of surface hydrophobicity on the conformational changes of adsorbed fibrinogen. J. Colloid Interface Sci. 144 (1991), 271–281.
-
(1991)
J. Colloid Interface Sci.
, vol.144
, pp. 271-281
-
-
Lu, D.R.1
Park, K.2
-
49
-
-
84983469620
-
-
Hindawi Publishing Corporation
-
[49] Khot, G., Kuforiji, F., Wright, R., Roach, P., Dynamic Assessment of Fibrinogen Adsorption and Secondary Structure Perturbation, Conference Papers in Science, 2014, Hindawi Publishing Corporation.
-
(2014)
Dynamic Assessment of Fibrinogen Adsorption and Secondary Structure Perturbation, Conference Papers in Science
-
-
Khot, G.1
Kuforiji, F.2
Wright, R.3
Roach, P.4
-
50
-
-
28944449298
-
Conformational changes of fibrinogen after adsorption
-
[50] Clarke, M.L., Wang, J., Chen, Z., Conformational changes of fibrinogen after adsorption. J. Phys. Chem. B 109 (2005), 22027–22035.
-
(2005)
J. Phys. Chem. B
, vol.109
, pp. 22027-22035
-
-
Clarke, M.L.1
Wang, J.2
Chen, Z.3
-
51
-
-
0034602773
-
Transglutaminase-catalyzed crosslinking of the Aα and γ constituent chains in fibrinogen
-
[51] Murthy, S.P., Wilson, J.H., Lukas, T.J., Veklich, Y., Weisel, J.W., Lorand, L., Transglutaminase-catalyzed crosslinking of the Aα and γ constituent chains in fibrinogen. Proc. Natl. Acad. Sci. 97 (2000), 44–48.
-
(2000)
Proc. Natl. Acad. Sci.
, vol.97
, pp. 44-48
-
-
Murthy, S.P.1
Wilson, J.H.2
Lukas, T.J.3
Veklich, Y.4
Weisel, J.W.5
Lorand, L.6
-
52
-
-
33845567319
-
Fluorescence spectroscopy evaluation of fibrinogen–β-estradiol binding
-
[52] Gonçalves, S., Santos, N.C., Martins-Silva, J., Saldanha, C., Fluorescence spectroscopy evaluation of fibrinogen–β-estradiol binding. J. Photochem. Photobiol. B Biol. 86 (2007), 170–176.
-
(2007)
J. Photochem. Photobiol. B Biol.
, vol.86
, pp. 170-176
-
-
Gonçalves, S.1
Santos, N.C.2
Martins-Silva, J.3
Saldanha, C.4
-
53
-
-
0018126837
-
Functional consequences of tryptophan modification in human fibrinogen
-
[53] Ishida, Y., Takiuchi, H., Matsushima, A., Inada, Y., Functional consequences of tryptophan modification in human fibrinogen. Biochimica et Biophysica Acta (BBA) - Protein Structure 536 (1978), 70–77.
-
(1978)
Biochimica et Biophysica Acta (BBA) - Protein Structure
, vol.536
, pp. 70-77
-
-
Ishida, Y.1
Takiuchi, H.2
Matsushima, A.3
Inada, Y.4
-
54
-
-
81755161511
-
Fibrin clot structure and function: a role in the pathophysiology of arterial and venous thromboembolic diseases
-
[54] Undas, A., Ariëns, R.A.S., Fibrin clot structure and function: a role in the pathophysiology of arterial and venous thromboembolic diseases. Arterioscler. Thromb. Vasc. Biol. 31 (2011), e88–e99.
-
(2011)
Arterioscler. Thromb. Vasc. Biol.
, vol.31
, pp. e88-e99
-
-
Undas, A.1
Ariëns, R.A.S.2
-
55
-
-
28344448202
-
Fibrinogen and fibrin structure and functions
-
[55] Mosesson, M., Fibrinogen and fibrin structure and functions. J. Thromb. Haemost. 3 (2005), 1894–1904.
-
(2005)
J. Thromb. Haemost.
, vol.3
, pp. 1894-1904
-
-
Mosesson, M.1
-
56
-
-
0033848526
-
Cardioprotective effects of 17β-estradiol produced by activation of mitochondrial ATP-sensitive K + channels in canine hearts
-
[56] Lee, T.-M., Su, S.-F., Tsai, C.-C., Lee, Y.-T., Tsai, C.-H., Cardioprotective effects of 17β-estradiol produced by activation of mitochondrial ATP-sensitive K + channels in canine hearts. J. Mol. Cell. Cardiol. 32 (2000), 1147–1158.
-
(2000)
J. Mol. Cell. Cardiol.
, vol.32
, pp. 1147-1158
-
-
Lee, T.-M.1
Su, S.-F.2
Tsai, C.-C.3
Lee, Y.-T.4
Tsai, C.-H.5
-
57
-
-
0032976312
-
Cardiovascular disease: pathogenesis, epidemiology, and risk among users of oral contraceptives who smoke
-
[57] Castelli, W.P., Cardiovascular disease: pathogenesis, epidemiology, and risk among users of oral contraceptives who smoke. Am. J. Obstet. Gynecol. 180 (1999), S349–S356.
-
(1999)
Am. J. Obstet. Gynecol.
, vol.180
, pp. S349-S356
-
-
Castelli, W.P.1
-
58
-
-
69449104248
-
Ovarian hyperstimulation syndrome and complications of ART
-
[58] Vloeberghs, V., Peeraer, K., Pexsters, A., D'Hooghe, T., Ovarian hyperstimulation syndrome and complications of ART. Best Practice & Research Clinical Obstetrics & Gynaecology 23 (2009), 691–709.
-
(2009)
Best Practice & Research Clinical Obstetrics & Gynaecology
, vol.23
, pp. 691-709
-
-
Vloeberghs, V.1
Peeraer, K.2
Pexsters, A.3
D'Hooghe, T.4
-
59
-
-
84945442272
-
Hormone therapy and risk of venous thromboembolism among postmenopausal women
-
[59] Canonico, M., Hormone therapy and risk of venous thromboembolism among postmenopausal women. Maturitas 82 (2015), 304–307.
-
(2015)
Maturitas
, vol.82
, pp. 304-307
-
-
Canonico, M.1
-
60
-
-
39449089221
-
The influence of sex hormones on coagulation and inflammation in the trauma patient
-
[60] Gee, A.C., Sawai, R.S., Differding, J., Muller, P., Underwood, S., Schreiber, M.A., The influence of sex hormones on coagulation and inflammation in the trauma patient. Shock 29 (2008), 334–341.
-
(2008)
Shock
, vol.29
, pp. 334-341
-
-
Gee, A.C.1
Sawai, R.S.2
Differding, J.3
Muller, P.4
Underwood, S.5
Schreiber, M.A.6
-
61
-
-
0031839983
-
Conjugated estrogen reduces transfusion and coagulation factor requirements in orthotopic liver transplantation
-
[61] Frenette, L., Cox, J., McArdle, P., Eckhoff, D., Bynon, S., Conjugated estrogen reduces transfusion and coagulation factor requirements in orthotopic liver transplantation. Anesth. Analg. 86 (1998), 1183–1186.
-
(1998)
Anesth. Analg.
, vol.86
, pp. 1183-1186
-
-
Frenette, L.1
Cox, J.2
McArdle, P.3
Eckhoff, D.4
Bynon, S.5
-
62
-
-
84955725930
-
Tissue factor pathway inhibitor, activated protein C resistance, and risk of coronary heart disease due to combined estrogen plus progestin therapy
-
ATVBAHA. 115.306905
-
[62] Johnson, K.C., Aragaki, A.K., Jackson, R., Reiner, A., Sandset, P.M., Rosing, J., et al. Tissue factor pathway inhibitor, activated protein C resistance, and risk of coronary heart disease due to combined estrogen plus progestin therapy. Arterioscler. Thromb. Vasc. Biol., 2015 ATVBAHA. 115.306905.
-
(2015)
Arterioscler. Thromb. Vasc. Biol.
-
-
Johnson, K.C.1
Aragaki, A.K.2
Jackson, R.3
Reiner, A.4
Sandset, P.M.5
Rosing, J.6
-
63
-
-
84883169320
-
Heparanase procoagulant activity is elevated in women using oral contraceptives
-
[63] Matan, M., Axelman, E., Brenner, B., Nadir, Y., Heparanase procoagulant activity is elevated in women using oral contraceptives. Hum. Reprod. 28 (2013), 2372–2380.
-
(2013)
Hum. Reprod.
, vol.28
, pp. 2372-2380
-
-
Matan, M.1
Axelman, E.2
Brenner, B.3
Nadir, Y.4
|